Keywords: عامل فون ویلبراند; ventricular assist device; von Willebrand factor; bleeding; shear stress; multimer; ADAMTS13;
مقالات ISI عامل فون ویلبراند (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل فون ویلبراند; vWF; von Willebrand factor; STEMI; ST elevation myocardial infarction; CAD; coronary artery disease; VEC; vascular endothelial cell; LEC; lymphatic endothelial cell; Endothelial cell; Surface marker; CD34; CD31; VEGF; VEGFR2;
Keywords: عامل فون ویلبراند; ADP; adenosine diphosphate; CAM; cell adhesion molecule; CLEC2; C-type lectin-like receptor-2; COX-2; cyclooxygenase-2; CTCs; circulating tumor cells; G-CSF; granulocyte colony-stimulation factor; Gp; Glycoproteins; GPCRs; G Protein-coupled Receptors; IL-
Keywords: عامل فون ویلبراند; 1-OHP; 1-hydroxypyrene; 3-NT; 3-nitrotyrosine; 8-oxodGuo; 8-oxo-7,8-dihydro-2'-deoxyguanosine; 15-F2t-IsoP; 15-F2t-isoprostane; +dP/ dt; rate of change of pressure development; -dP/dt; rate of change of pressure decay; Ach; acetylcholine; p-AKT; phospho
Keywords: عامل فون ویلبراند; 11KT; 11-ketotestosterone; 17bhsd; 17β-hydroxysteroid dehydrogenase; 17P; 17α-hydroxyprogesterone; 17,20bP; 17,20β-dihydroxy-4-pregnen-3-one; 20b-HSD; 20β-hydroxysteroid dehydrogenase; 20βS; 17,20β,21-trihydroxy-4-pregnen-3-one; actRIIB; activin rec
Keywords: عامل فون ویلبراند; Aortic stenosis; Coagulation; Bleeding; von Willebrand factor; Valve replacement; Heyde syndrome
Keywords: عامل فون ویلبراند; aPTT; activated partial thromboplastin time; AT; antithrombin; CAT; calibrated automated thrombography; ETP; endogenous thrombin potential; F1Â +Â 2; prothrombin fragments F1Â +Â 2; FII; prothrombin; FVIII:C; factor VIII coagulant activity; IDDM; insulin-
Keywords: عامل فون ویلبراند; Cerebral hemorrhage; von Willebrand factor; ADAMTS13; plasminogen activators;
Keywords: عامل فون ویلبراند; (AFib); atrial fibrillation; (LAA); left atrial appendage; (ECs); endothelial cells; (F3); tissue factor; (vWF); von Willebrand Factor; (ANGPT2); angiopoietin 2; (KFL2); kruppel-like factor-2; (eNOS); endothelial nitric oxide synthase; (ECM); extracellula
Keywords: عامل فون ویلبراند; Type 2 diabetes; Obesity; Diet; Endothelial dysfunction; Inflammation; ACE inhibitor; angiotensin-converting enzyme inhibitor; BMI; body mass index; ELISA; enzyme-linked immunosorbent assay; HbA1c; glycated hemoglobin; HDL; high-density lipoprotein; hs-CR
Keywords: عامل فون ویلبراند; Antithrombin; Coagulation; Disseminated intravascular coagulation; High mobility group box protein; Histones; Protein C; Thrombomodulin; Von willebrand factor
Keywords: عامل فون ویلبراند; BMI; body mass index; CI; confidence interval; CRP; C-reactive protein; CVD; cardiovascular disease; ET-1; endothelin-1; GCSF; Granulocyte-colony stimulating factor; IL-1b; interleukin-1b; IL-6; interleukin-6; IL-8; interleukin-8; IL-10; interleukin-10; M
Keywords: عامل فون ویلبراند; Testicular neoplasms; Chemotherapy, adjuvant; Cisplatin; Bleomycin; Cardiovascular diseases; Carotid intima media thickness; Von Willebrand factor; Factor VIII; Risk factors; Growth differentiation factor 15;
Keywords: عامل فون ویلبراند; APC; antigen-presenting cells; BcR; B cell receptor; EMA; European Medicines Agency; Fc; crystallizable fragment; FcγR; receptor for IgG Fc portion; FcRn; neonatal Fc receptor; FVIIa; activated factor VII; FVIII; factor VIII; GLP-1; glucagon-like peptide
Keywords: عامل فون ویلبراند; CLA; Chemiluminescent assay; ELISA; enzyme linked immunosorbent assay; FVIII:C; FVIII coagulant; GPIb; glycoprotein Ib; HMW; high molecular weight (VWF); LIA; latex-particle immuno-assay; VWD; von Willebrand disease; VWF; von Willebrand factor; VWF Ac; VW
Keywords: عامل فون ویلبراند; AASLD; Association for the Study of Liver Disease; ACLF; acute-on-chronic liver failure; AICF; accelerated intravascular coagulation and fibrinolysis; ALF; acute liver failure; aPTT; activated partial thromboplastin time; CLD; chronic liver disease; DDAVP
Keywords: عامل فون ویلبراند; atypical hemolytic uremic syndrome; blood outgrowth endothelial cells; complement; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; von Willebrand factor;
Keywords: عامل فون ویلبراند; iPSC; induced pluripotent stem cell; hiPSC; human induced pluripotent stem cell; iPSC-EC; induced pluripotent stem cell-derived endothelial cell; EC; endothelial cell; HCAEC; human coronary artery endothelial cells; vWF; von Willebrand factor; Ac-LDL; ace
Keywords: عامل فون ویلبراند; cardiac valves; cardiac valve prosthesis; pulmonary valve; bioengineering; tissue engineering; allografts; α-SMA; alpha smooth muscle actin; BEHV; bioengineered heart valve; BEPV; bioengineered pulmonary valve; BSA; body surface area; CryoV; cryopreserve
Keywords: عامل فون ویلبراند; AvWS; acquired von Willebrand syndrome; BTT; bridge to transplant; CF; continuous flow; DT; destination therapy; FDA; Food and Drug Administration; GI; gastrointestinal; HF; heart failure; HM; HeartMate; HTx; heart transplant; INR; international normalize
Keywords: عامل فون ویلبراند; von Willebrand disease; VWD; diagnosis; von Willebrand factor; VWF; laboratory testingADAMTS-13, a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CB/Ag, collagen binding to antigen ratio; CLIA, chemiluminescent immunoassa
Keywords: عامل فون ویلبراند; BBB; blood-brain barrier; BSA; bovine serum albumin; cAMP; cyclic adenosine monophosphate; CGRP; calcitonin gene-related peptide; CHO; Chinese hamster ovary; CLR; calcitonin receptor-like receptor; CNS; central nervous system; DAB; 3,3â²-diaminobenzidi
Keywords: عامل فون ویلبراند; Aβ; amyloid beta; AD; Alzheimer's disease; AIS; acute ischaemic stroke; AJ; adherens junctions; ApoE; apolipoprotein E; APP; amyloid precursor protein; BBB; blood-brain barrier; BMVEC; brain microvascular endothelial cells; CD; cluster of differentiation
Keywords: عامل فون ویلبراند; atypical haemolytic—uraemic syndrome; complement system; pHUS; Shiga toxin-mediated haemolytic—uraemic syndrome; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; von Willebrand factor
Keywords: عامل فون ویلبراند; 2K-1C; two-kidney one-clip; ACE-Is; angiotensin converting enzyme inhibitors; AL; aliskiren; Ang II; angiotensin II; ANP; atrial natriuretic peptide; APTT; activated partial thromboplastin time; ARBs; AT1 receptor antagonists; ASA; aspirin; Fg; fibrinogen
Keywords: عامل فون ویلبراند; Thal; Thalidomide; VTE; venous thrombosis; Dex; dexamethasone; vWF; von Willebrand factor; ECs; endothelial cells; IL-6; interleukin-6; TNFα; tumor necrosis factor; HUVECs; human umbilical vein endothelial cells; DMSO; dimethyl sulfoxide; FITC; Fluoresce
Keywords: عامل فون ویلبراند; Severe mental disorders; Inflammation; Wechsler Abbreviated Scale of Intelligence (WASI); Cognitive; sTNF-R1; IL-1Ra; Osteoprotegerin; IL-6; hsCRP; Von Willebrand factor
Keywords: عامل فون ویلبراند; AS; aortic stenosis; AVM; arteriovenous malformation; avWD; acquired von Willebrand disease; GI; gastrointestinal; LVAD; left ventricular assist device; vWF; von Willebrand factor;
Keywords: عامل فون ویلبراند; AF; atrial fibrillation; CHADS2; Congestive heart failure, Hypertension, Age >75 years, Diabetes mellitus, and Stroke/transient ischemic attack; INR; international normalized ratio; LAAT; left atrium appendage thrombus; NVAF; nonvalvular atrial fibrillati
Keywords: عامل فون ویلبراند; Lectin; von Willebrand factor; Factor IX; Hamster cell lines; Sambucus nigra agglutinin (SNA)
Keywords: عامل فون ویلبراند; 27; 29; 37; ADAMTS-13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; LVAD; left ventricular assist device; SDS; sodium dodecyl sulfate; TBS; Tris-buffered saline; vWF; von Willebrand factor;
Keywords: عامل فون ویلبراند; Enfermedad de von Willebrand; Factor de von WillebrandVon Willebrand disease; Von Willebrand factor
Keywords: عامل فون ویلبراند; Malaria; Asymptomatic; Platelets; Inflammation; Endothelium; Plasmodium falciparum; Plasmodium vivax; von Willebrand factor; Anemia;
Keywords: عامل فون ویلبراند; Endothelial cell; Leptospirosis; E-selectin; Von Willebrand factor; sFas ligand; sIL-2 receptor;
Keywords: عامل فون ویلبراند; cardiovascular magnetic resonance imaging; drug delivery system; growth factor; myocardial repair; tissue engineering; CMR; cardiovascular magnetic resonance; ECM; extracellular matrix; ECV; extracellular volume fraction; FGF-2; basic fibroblast growth fa
Keywords: عامل فون ویلبراند; ADAM; A Disintegrin And Metalloprotease Domain; AHR; airway hyperreponsiveness; Ang; angiopoietin; ASM; airway smooth muscle; BALf; bronchoalveolar lavage fluid; bFGF; basic fibroblast growth factor; BM; basement membrane; Col; collagen; CTGF; connective
Keywords: عامل فون ویلبراند; Endoscopy; Cardiovascular Disease; Heart Failure; Pulsatile and Continuous Devices; ESHD; end-stage heart disease; GI; gastrointestinal; GIB; gastrointestinal bleeding; LVAD; left ventricular assist device; VAD; ventricular assist device; vWF; von Willebr
Keywords: عامل فون ویلبراند; ADAMTS-13; a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13; CV; coefficient of variation; EDTA; ethylenediaminetetraacetic acid; ELISA; enzyme-linked immunosorbent assay; EMSI; Examination Management Services, Inc.; ERL;
Keywords: عامل فون ویلبراند; Endothelial dysfunction; Tissue plasminogen activator; Von Willebrand factor; Cerebral blood flow;
Keywords: عامل فون ویلبراند; HPS; hepatopulmonary syndrome; vWF-Ag; von Willebrand factor antigen; MELD; model for endstage-liver disease; IPVD; intrapulmonary vasodilation; vWF; von Willebrand factor; FEV1; forced expiratory volume in one second; FVC; forced vital capacity; AaPO2; a
Keywords: عامل فون ویلبراند; Mevastatin (PubChem CID: 64715); Atorvastatin (PubChem CID: 60823); Simvastatin (PubChem CID: 54454); Losartan (PubChem CID: 3961); Valsartan (PubChem CID: 60846); EC; endothelial cell; eNOS; endothelial NO synthase; DiI-Ac-LDL; 1,1â²-dioctadecyl-3,3,3â
Keywords: عامل فون ویلبراند; 5â²N; 5â²-nucleotidase; AD; adenosine deaminase; AK; adenosine kinase; AOPCP; α,β methylene ADP; Km; Michaelis constant; MACS; magnetic-activated cell sorting; PBS; phosphate-buffered saline; VEC; vascular endothelial cell; VEGF; vascular endothelial
Keywords: عامل فون ویلبراند; SAH; Subarachnoid hemorrhage; EBI; Early brain injury; SphK; Sphingosine kinase; S1P; Sphingosine 1-phosphate; S1P1/3; Sphingosine-1-phosphate receptor-1/3; BWC; Brain water content; iba-1; Ionized calcium binding adaptor molecule-1; MPO; Myeloperoxidase;
Keywords: عامل فون ویلبراند; A/C; anticoagulant therapy; APC; activated protein C; CRP; C-reactive protein; DVT; deep vein thrombosis; ELISA; enzyme-linked immunosorbent assay; HI; healthy individuals; Il-6/8; interleukin 6/8; IQR; interquartile range; MMP-9; matrixmetalloprotease 9;
Keywords: عامل فون ویلبراند; α-SMA; α-smooth muscle actin; vWF; von Willebrand factor; HIF-1α; hypoxia-inducible factor-1α; TNF-α; tumour necrosis factor-α; COX-2; cyclooxygenase-2; VEGF; vascular endothelial growth factor; TGF-βR1; transforming growth factor-β receptor 1; An
Keywords: عامل فون ویلبراند; Ac-LDL; acetylated-low density lipoprotein; α-SMA; α-smooth muscle actin; BM-MSCs; bone marrow mesenchymal stem cells; CD; cluster of differentiation; DAPI; 4â²,6-diamidino-2-phenylindole; DePV; decellularized pulmonary valve; DMEM; Dulbecco Modified E
Keywords: عامل فون ویلبراند; Skin; Aging; Angiogenesis; Blood vessels; Von Willebrand factor; CD31; VEGF; Dll4; Jag-1;
Keywords: عامل فون ویلبراند; Abdominal aortic aneurysms; Atherosclerosis; Vascular disease; Inflammation; Lymphocytes; AAA; abdominal aortic aneurysm; EvG; elastin von Gieson; H&E; hematoxylin and eosin; IFN; interferon; IL; Interleukin; MMP; Matrix metalloproteinase; PET/CT; positro
Keywords: عامل فون ویلبراند; IL-6; Interleukin-6; DXA; dual energy x-ray absorptiometry; BMI; body mass index; HDL; high-density lipoprotein; PPARγ; the nuclear hormone receptor peroxisome proliferator-activated receptor γ; CEBP; CCAAT/enhancer binding protein; PLIN; perilipin; GLU
Keywords: عامل فون ویلبراند; Facteur von Willebrand; maladie de Willebrand; Von Willebrand factor; von Willebrand disease;